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ABSTRACT 1 
Background: Metabolic Syndrome (MetS) as a combination of features has been known to 2 
significantly increase Cardiovascular Disease (CVD) risk, whilst MetS presence is linked to 3 
lifestyle parameters including physical activity and dietary habits; recently, the potential 4 
impact of sleeping habits has also become an issue under consideration. The aim of this study 5 
was to investigate the role of sleep quantity in several MetS components. Methods: Design: 6 
Cross-sectional observational study. Setting: 26 Mediterranean islands and the rural Mani 7 
region (Peloponnesus) of Greece. Participants: during 2005-2017, 3130 older (aged 65-100 8 
years) Mediterranean residents were voluntarily enrolled. Measurements: Dietary habits 9 
(including MedDietScore assessment), physical activity status, socio-demographic 10 
characteristics, lifestyle parameters (sleeping and smoking habits) and clinical profile aspects 11 
including Metabolic Syndrome (MetS) components (i.e., waist circumference, systolic and 12 
diastolic blood pressure, fasting glucose, triglycerides, LDL and HDL-cholesterol) were 13 
derived through standard procedures. Results: The number of daily hours of sleep was 14 
independently associated with greater waist circumference (b coefficient per 1 hour=0.91, 15 
95% Confidence Interval (CI); 0.34, 1.49), higher LDL-cholesterol levels (b per 1 hour=3.84, 16 
95%CI; 0.63, 7.05) and  lower diastolic blood pressure levels (b per 1 hour=-0.98, 95%CI; -17 
1.57, -0.39) after adjusting for participants’ age, gender, body mass index, daily walking 18 
time, level of adherence to Mediterranean diet and smoking status. No association was 19 
revealed between hours of sleep per day and fasting glucose, triglycerides, HDL-cholesterol 20 
and systolic blood pressure. Conclusions: Increased hours of sleep is an indicator of 21 
metabolic disorders among elderly inviduals, and further research is needed to identify the 22 
paths through which sleep quantity is linked to MetS features in different age-groups. 23 
Keywords: Metabolic Syndrome components; Sleep; Elderly; Lifestyle; MEDIS; 24 
Mediterranean-type diet 25 
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INTRODUCTION 1 
The metabolic syndrome (MetS) has been defined as “multiple, interrelated factors 2 
that raise cardiovascular disease (CVD) risk” (1, 2, 3). The classic definition includes 3 
presence of several metabolic risk factors, such as insulin resistance, central obesity, 4 
dyslipidemia and elevated blood pressure levels, with recent research expanding these to 5 
include chronic stress, inflammation processes, and epigenetic interactions (2). This has 6 
brought into question clinical value of confirming a diagnosis of MetS to identify individuals 7 
at risk of CVD, as it may exclude people with increased risk that do not present with the 8 
minimum of three or more risk factors (4). Thus, suggesting that identifying and managing 9 
risk associated with the individual isolated characteristics of MetS could be of equal if not 10 
greater clinical importance than diagnosing MetS (5). 11 
The role of lifestyle factors particularly those beyond diet (5) and physical activity (6) 12 
in relation to CVD risk and MetS is an area of increasing interest. This includes associations 13 
between social interaction, depression and risk of CVD (7) and have included investigations 14 
which found associations between sleeping pattern including daytime sleeping and MetS risk 15 
(8). Increasing evidence of the potential role of sleep in MetS components has recently 16 
emerged in the literature, meta-analysis in 2015 of 21 studies found a robust and consistent 17 
negative association between insufficient sleep and waist circumference (9). This aligns with 18 
a separate review, which found an increased risk for MetS in short, but not in longer duration 19 
sleepers (10). However, the mechanism of how sleep duration may influence MetS risk is 20 
unclear. Moreover, elevated blood pressure and glucose dysregulation has been proposed as a 21 
primary driver behind the excess in mortality risk in short-duration sleepers (11). The impact 22 
of sleep deprivation on the endocrine system is complex and include decreased insulin 23 
sensitivity, and dysregulation of hormonal pathways including cortisol, leptin and insulin-24 
like-growth factor-1 (12). Furthermore, sleep deprivation modifies inflammatory and 25 
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cholesterol pathways associated with increased CVD risk at both the transcriptome level and 1 
in the circulating lipid profile (13, 14). This implies that the effect of sleep deprivation 2 
impacts on the component factors of MetS, and as such merits investigation.  3 
 Despite understanding the impact of lack of sleep on metabolic risk, little is known 4 
regarding the association of sleep quantity on MetS features, ESPECIALLY in older adult 5 
population. Moreover, older people residing in the Mediterranean region have attracted 6 
considerable scientific and public interest, surrounding their lifestyle and dietary factors, as 7 
potentially preventative and curative for several health conditions (15-19). Recently, the 8 
MEDIS group has shown that sleeping during the day (siesta) is positively associated with 9 
odds of hypertension (7). To our knowledge, no study has investigated the relationship 10 
between the quantity of sleep and the individual component factors of MetS in elderly 11 
individuals. Thus, the aim of the present work was to evaluate the associations between sleep 12 
quantity and MetS features’ in elderly individuals from the Mediterranean region.    13 
 14 
MATERIALS AND METHODS 15 
Methodology 16 
The Mediterranean Islands (MEDIS) study is an ongoing, large-scale, multinational 17 
epidemiological project, which is exploring the association between lifestyle habits, psycho-18 
social characteristics, and living environment, on cardiometabolic factors, among older 19 
people (>65 years), residing in the Mediterranean area. 20 
The Study’s sample 21 
Between 2005-2017, a random population-based, multistage sampling method (i.e., age 22 
group, 3 levels (65 - 75, 75 - 85, 85+) and 2 sex levels) was used to voluntarily enrol older 23 
men and women people from 26 Mediterranean islands: including Malta Republic (n=250), 24 
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Sardinia (n=60) and Sicily (n=50), Mallorca and Menorca (n=111), Republic of Cyprus 1 
(n=300), Gökçeada (n=55) in Turkey, and the Greek islands of Lesvos (n=142), Samothraki 2 
(n=100), Cephalonia (n=115), Crete (n=131), Corfu (n=149), Limnos (n=150), Ikaria (n=76), 3 
Syros (n=151), Naxos (n=145), Zakynthos (n=103), Salamina (n=147), Kassos (n=52), 4 
Rhodes and Karpathos (n=149), Tinos (n=129), Ai-Stratis (n=30), Spetses (n=92), Aegina 5 
(n=59), Paros (n=90) as well as the rural region of East Mani (n=295, 157 men aged 75±7 6 
years and 138 women aged 74±7 years) (a Greek peninsula, which is in the southeast, 7 
continental area of Europe, with a total population of 13,005 people (census 2011), which has 8 
morphological and cultural specificities, which are not common across in the rest of Greece. 9 
Individuals who resided in assisted-living centres, had a clinical history of cardiovascular 10 
disease (CVD) or cancer, or had left the island for a considerable period of time during their 11 
life (i.e., >5 years) were excluded from participating in the study; these criteria were applied 12 
because the study aimed to assess lifestyle patterns that were not a response of individuals 13 
modifying how they live due to existing chronic health care conditions or by environmental 14 
factors, other than their living milieu. The participation rate varied according to the region, 15 
from 75% to 89%. Thus, information from 3130 individuals, 1,574 men, aged 75±8 years and 16 
1,556 women, aged 74±7 years, were analyzed. 17 
A multidisciplinary group of health scientists (physicians, dietitians, public health 18 
nutritionists, and nurses) with experience in field investigation collected all the required 19 
information using a quantitative questionnaire and standard procedures.  20 
Bioethics 21 
The study followed the ethical considerations provided by the World Medical Association 22 
(52
nd
 WMA General Assembly, Edinburgh, Scotland; October 2000). The Institutional Ethics 23 
Board of Harokopio University approved the study design (16/19-12-2006), as well as the 24 
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regional offices of the participated Institutions. Participants were informed about the aims 1 
and procedures of the study and gave their consent prior to being interviewed. 2 
Evaluation of clinical characteristics 3 
All of the measurements taken in the different study centers were standardized, and the 4 
questionnaires were translated into all of the cohorts’ languages following the World Health 5 
Organization (WHO) translation guidelines for tools assessment 6 
(www.who.int/substance_abuse/research_tools/translation/en/). Height and weight were 7 
measured using standard procedures to attain body mass index (BMI) scores (kg/m
2
). Waist 8 
circumference (cm) was measured at the midpoint between the 12
th
 rib and the iliac crest. 9 
Fasting blood lipids levels (HDL-c, LDL-c and triglycerides) and fasting glucose levels were 10 
also recorded. Blood pressure was either self-reported or, in most islands measured by trained 11 
physicians or nurses with participants in a sitting position and calm and the average of three 12 
measurements was calculated. The IDF Epidemiology Task Force group definition of MetS 13 
was used to identify individuals with MetS (3).  14 
Evaluation of lifestyle and socio-demographic characteristics 26 
Sleep was assessed estimating the amount of sleeping hours on a typical day while 27 
interviewing the participants using the self-reported Wake After Sleep Onset (WASO). The 28 
frequency and the hours of sleeping during the day, as well as the wake-up and going-to-sleep 29 
time were also recorded according to individuals self-reporting. Dietary habits were assessed 30 
through a semi-quantitative, validated and reproducible food-frequency questionnaire (20). 31 
Trained dietitians estimated the mean daily energy intake and the mean percentage of total 32 
energy derived from dietary carbohydrates. To evaluate the level of adherence to the 33 
Mediterrenean diet, the MedDietScore (possible range 0-55) was used (21). Higher values for 34 
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this diet score being indicative of greater adherence to the Mediterranean diet. Participants 1 
were also encouraged to report the duration of following their dietary pattern (i.e., the number 2 
of years this pattern had been in place). Basic socio-demographic characteristics such as age, 3 
sex, as well as lifestyle characteristics, such as smoking habits and physical activity status, 4 
were also recorded. Current smokers were defined as smokers at the time of the interview, 5 
whereas former smokers were defined as those who previously smoked, but had not done so 6 
for a year or more. Current and former smokers were defined as had ‘ever smokers’. The 7 
remaining participants were assigned as occasional or non-smokers. Physical activity was 8 
evaluated in MET-minutes per week, using the shortened, translated and validated into 9 
Greek, version of the self-reported International Physical Activity Questionnaire (IPAQ) (22, 10 
23). Frequency (times per week), duration (minutes per session) and intensity of physical 11 
activity during sports, occupation, and leisure activities were assessed. Participants were 12 
instructed to report only episodes of activity lasting at least 10 minutes since this is the 13 
minimum required to achieve health benefits. Physically active individuals were defined 14 
those who reported at least 3 MET-min. Daily walking time was calculated by using the 15 
IPAQ question about walking (times per week and average time spent). 16 
Further details about the MEDIS study have extensively been published elsewhere 17 
(24, 25). 18 
Statistical analysis 19 
Continuous variables are expressed as mean ± standard deviation for variables following 20 
assessing for normal distribution, or median (inter-quartile range) for variables not following 21 
a normal distribution. Normality was tested using P-P plots. Differences in continuous 22 
variables between males and females were evaluated with the Student’s t-test for normally 23 
distributed parameters and the Mann-Whitney test for non-parametric variables. Correlations 24 
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between continuous variables were tested using Pearson’s r when both variables were 1 
normally distributed or Spearman’s rho when at least one of them did not have a normal 2 
distribution. Nominal variables are presented as frequencies and relative frequencies (%). 3 
Pearson’s Chi-square test was used to assess the association between two nominal variables. 4 
Linear regression models were used to evaluate the association between sleed duration, other 5 
participants’ characteristics (i.e., age, sex, BMI, physical activity, MedDietScore, smoking 6 
habits) and levels of the MetS components (fasting glucose levels, waist circumference, 7 
systolic and diastolic arterial blood pressure, triglycerides, LDL and HDL levels). 8 
Logarithmic transformation was used for the dependent variable that did not have a normal 9 
distribution (triglycerides and HDL-c). Results are expressed as b coefficients and the 95% 10 
confidence intervals. Type I error was predefined at 0.05. Statistical analysis was carried out 11 
in IBM SPSS version 23.0 (Armonk, NY: IBM Corp.). 12 
 13 
RESULTS 14 
Mean sleep duration time was 8.30±1.76 h per day, and specifically 8.30±1.75 h for 15 
men and 8.20±1.77 h for women (p=0.52). Moreover, sleep duration did not differ between 16 
retired and non-retired individuals (p=0.244), with the latter consisting 20.9% of the total 17 
sample. Sleep duration was positively associated with waist circumference (Pearson’s r=0.12, 18 
p=0.01) and LDL-c (Pearson’s r=0.23, p=0.001) and inversely associated with diastolic 19 
arterial blood pressure (Pearson’s r=-0.15, p=0.002). No association was observed between 20 
sleep and fasting glucose levels (p=0.20), systolic arterial blood pressure (p=0.59), fasting 21 
triglycerides (p=0.44) and HDL-c (p=0.47). MetS prevalence according to IDF criteria was 22 
65.3% and did not differ between genders (p=0.49). 23 
Mean BMI was 28.3±4.67 kg/m2, while the level of adherence to Mediterranean diet 24 
was 32.5±4.99 out of 55 (or 59% of ideal adherence), as calculated via the MedDietScore. 25 
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Regarding the MetS individual components, mean waist circumference 101±14.0 cm, mean 1 
fasting glucose 116±39.5 mg/dL and mean LDL-c 126±41.3 mg/dL with median HDL-c 50 2 
mg/dL and median triglyceride levels 119 mg/dL. Participants’ mean systolic and diastolic 3 
arterial blood pressures were 135±21.9 mmHg, and 77.6±13.0 mmHg respectively. 4 
Descriptive characteristics of the study sample, divided into two groups with respect to their 5 
gender, are summarized in Table 1.   6 
[Table 1] 7 
As presented in Table 1, females had higher BMI than males (28.9±5.10 kg/m2 vs. 8 
27.8±4.12 kg/m2 respectively, p<0.001), but their smoking prevalence was fivefold lower 9 
compared to men (5.2% vs. 26.1% respectively, p<0.001). No differences were revealed for 10 
their level of adherence to Mediterranean diet (p=0.88), daily walking time (p=0.24) nor their 11 
daily hours of sleep (p=0.53). As expected, females had lower waist circumference than men 12 
(100±15.1 cm vs. 102±12.3 cm respectively, p=0.001), higher HDL-c levels (55 (46,63) 13 
mg/dL vs. 46 (40,54) mg/dL, respectively, p<0.001) and lower LDL-c levels (129±22.6 14 
mg/dL vs. 123±39.3 mg/dL, respectively, p=0.026). Interestingly, no differences were 15 
detected for triglycerides’ levels (p=0.55), fasting glucose levels (p=0.72), systolic (p=0.86) 16 
and diastolic (p=0.46) arterial blood pressure levels. 17 
Characteristics of the participants according to their MetS status are presented in 18 
Table 2. As expected, subjects with MetS had higher waist circumference than MetS-free 19 
subjects (107±10.4 cm vs. 96.8±12.5 cm respectively, p<0.001), lower HDL-c levels (49 20 
(42,58) mg/dL vs. 56 (49,62) mg/dL, respectively, p<0.001), higher LDL-c levels (130±40.2 21 
mg/dL vs. 115±44.1 mg/dL, respectively, p=0.003), higher BMI (30.8±4.37 kg/m2 vs. 22 
28.2±3.81 kg/m2 respectively, p<0.001), higher fasting glucose levels (126±36.9 mg/dL vs. 23 
101±36.1 mg/dL, respectively, p<0.001), higher triglycerides’ levels (132 (102,177) mg/dL 24 
vs. 100 (86,119) mg/dL, respectively, p<0.001), higher systolic (138±15.4 mmHg vs. 25 
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123±14.2 mmHg, respectively, p<0.001) and diastolic arterial blood pressure levels 1 
(79.5±9.62 mmHg vs. 74.9±9.96 mmHg, respectively, p<0.001), as well as less daily walking 2 
time (60 (30,120) minutes/day vs. 120 (30,240) minutes/day respectively, p<0.001). 3 
Interestingly, no differences were detected for gender (p=0.49), age (p=0.50), daily hours of 4 
sleep (p=0.42), smoking status (p=0.76), nor their level of adherence to Mediterranean diet 5 
(p=0.53). No significant interaction between gender and sleep duration was detected when 6 
MetS presence is regarded.  7 
[Table 2] 8 
Table 3 and Figure 1 present the multivariable linear regression models that were 9 
implemented with the MetS individual component factors (waist circumference, fasting 10 
glucose levels, LDL-c and HDL-c levels, triglycerides levels, systolic and diastolic arterial 11 
blood pressure) as dependent variables. Total daily hours of sleep was independently 12 
associated with greater waist circumference in the age and gender adjusted model (b per 1 13 
hour=0.70, 95%CI; 0.07, 1.32) which remained significant and became stronger after 14 
adjusting for lifestyle factors such as smoking, daily walking, MedDietScore and BMI (b per 15 
1 hour=0.91, 95%CI; 0.34, 1.49). When LDL-c levels are regarded, the daily hours of 16 
sleeping was a significant independent variable in the age and gender adjusted model (b per 1 17 
hour=5.14, 95%CI; 2.10, 8.19), whilst in the final model it remained significant, but the 18 
effect size decreased (b per 1 hour=3.84, 95%CI; 0.63, 7.05). Total daily hours of sleep were 19 
independently and equally associated with lower diastolic blood pressure levels in the age 20 
and gender adjusted model (b per 1 hour=-0.92, 95%CI; -1.49, -0.34) and the multi-adjusted 21 
model (b per 1 hour=-0.98, 95%CI; -1.57, -0.39). No associations were revealed between 22 
hours of sleep per day and fasting glucose, triglycerides, and systolic arterial blood pressure 23 
levels in any of the the multivariable models.  24 
[Table 3] 25 
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[Figure 1] 1 
DISCUSSION 2 
This analysis has demonstrated that self-reported sleep duration can have variable effects on 3 
the individual component factors used in the diagnosis of MetS in a relatively healthy elderly 4 
cohort residing in the Mediterranean area. Using a component analysis of sleep quantity, 5 
individuals with greater duration of total sleep are more likely to have a higher waist 6 
circumference and LDL-c. More specifically, for every hour increase in total sleep waist 7 
circumference is expected to rise per 1 cm and LDL-cholesterol per approximately 4 mg/dL, 8 
even when important confounders were considered. From a clinical point of view, these 9 
findings could provide the clinicians an important lifestyle parameter to assess for elderly 10 
individuals.  On the other hand, increased total sleep hours were found to be associated with 11 
slight decrease in diastolic blood pressure, but not of clinical importance. Interestingly, no 12 
associations were observed between sleep duration with respect to fasting glucose, 13 
triglycerides, HDL-c levels and systolic blood pressure. This is suggestive of a mixed effect 14 
of sleep quantity on features of MetS, with four of the seven features not being influenced by 15 
sleep duration and this can explain the lack of association between hours of sleep and the 16 
MetS as an entity.  17 
  Over the last decade, there has been a growth in research describing the impact of 18 
short sleep duration (10, 26-28), yet few have attempted to elucidate the risks associated with 19 
over-sleeping. In studies inclusive of all adults, longer sleep duration may be protective of 20 
MetS (29, 30). However, this is believed to be the first study examining the association 21 
between the individual component features of MetS and sleep quantity in a relatively healthy 22 
elderly cohort. In the Mediterranean area, MetS is estimated to affect 20-25% of individuals 23 
(31), with prevalence as high as 46.8% using NCEP-ATPIII criteria (32). These data 24 
highlight the need to understand the optimal sleep range to promote positive health and well-25 
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being relative to the components of MetS in an aging population and the need for sleep 1 
duration to be assessed in the clinical setting. Furthermore, this needs to be incorporated as 2 
part of a holistic preventative lifestyle approach, considering social factors alongside physical 3 
activity, diet and mental wellbeing (7). 4 
The association of waist circumference to CVD and diabetes risk factors has been 5 
well described (33). In this cohort, the association of an increased waist circumference for 6 
each hour of sleep was demonstrated independent of other CVD risk factors such as age, 7 
gender, BMI and lifestyle characteristics. These findings highlight that an increased waist 8 
circumference and the presence of visceral adiposity could indicate the presence of insulin 9 
resistance and chronic low-grade inflammation. The production of adipocytokines from the 10 
central adipose tissue is implicated in atherogenic dyslipidemia such as high serum 11 
triglycerides and low HDL-c (34), however, this was not associated with sleep duration in 12 
this cohort. In research using participants with obstructive sleep apnea, each hour of 13 
additional sleep was associated with a seven percent increase in interleukin-6 (IL-6) and an 14 
eight percent increase in C-reactive protein (CRP) (35). The Women’s Health Study (36) 15 
found both IL-6 and CRP to be associated with increased waist circumference, BMI, and 16 
waist-to-hip ratio. Other adipocytokines including leptin, resistin, tumor necrosis factor α and 17 
angiotensin II have also been related to insulin resistance and visceral fat accumulation (37). 18 
The role of a genetic predisposition towards obesity, waist circumference and BMI has been 19 
observed in a UK cohort, which suggested this effect was moderated by sleep amongst other 20 
lifestyle characteristics (38). This study found short and long sleep duration to compound the 21 
influence of a genetic predisposition towards obesity. Collectively, these findings indicate a 22 
need for a focus on the reversing central adiposity which is associated inflammation. This 23 
research supports the view that clinician should consider sleep management alongside other 24 
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lifestyle advice such as diet and physical activity in the treatment and prevention of MetS and 1 
CVD risk.  2 
The link between MetS and CVD risk in older adults of the Mediterranean region has 3 
been previously reported, with an increase in the likelihood of CVD by 83% in individuals 4 
from Athens, Greece (2). Elevated triglycerides and LDL-c, as along with lower levels of 5 
HDL-c, are associated with CVD risk, although the presented model only found an 6 
association between sleep duration per hour and increased LDL-c. Previously, high waist 7 
circumference has been demonstrated to be associated with elevated oxidized LDL-c 8 
independent of BMI in healthy older adults from Spain (39). This again suggests that low-9 
grade chronic inflammation may induce oxidative stress through the release of 10 
adipocytokines. While optimal sleep increases the ability to process moderate oxidative 11 
stress, this data may be explained by diminishing returns in the presence of higher than 12 
optimal sleep quantity.  13 
While these findings suggest that extra sleep may have detrimental effects in this 14 
cohort, it also poses the question as to why individuals with these risk factors may be 15 
sleeping more. This analysis include a relatively healthy cohort, evident by adherence to an 16 
MD diet and 60 minutes (median) of daily walking time. Adherence to an MD has been 17 
inversely associated with the risk of MetS, impaired fasting glucose, and insulin resistance 18 
(40). It is plausible that a reverse cause-effect may be occurring with individuals living with 19 
symptoms of MetS sleeping more, possibly including during the day (7). This highlights the 20 
need for greater identification of sleep habits and behaviors in clinical practice due to the 21 
potential moderating effect on MetS symptoms, preferably with more objective methods such 22 
as polysomnography that could also assess sleep quality (41).  23 
Questions remain as to whether MetS should be treated on an individual basis or 24 
whether the emphasis on a full lifestyle intervention is suitable to reduce disease risk (42). 25 
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Reaven suggested that the clustering of components of the MetS occur only in insulin 1 
resistant individuals and that focus on diagnosing MetS is unnecessary (4). Others contend 2 
that the identification of markers for MetS is crucial to treating the complex interaction 3 
between each component (37). The results from this healthy cohort, support the contention 4 
that each component, such as LDL-c, has individual importance, however it the lifestyle 5 
variable of sleep quantity that appeared to moderate these component features differently, 6 
suggesting that individual components of MetS need to be considered separately, even if 7 
treatment is holistic. While the model presented is relative to sleep quantity, it did account for 8 
other lifestyle factors. However, it cannot be ignored that broad lifestyle recommendations 9 
can improve MetS symptoms and CVD risk (7, 21, 43) and along with an adjunctive benefit 10 
that may be derived by sleep quantification in the clinical setting.   11 
Future research should aim to identify the reasons underlying the relationship between 12 
sleep quantity and the biochemical pathways impacting LDL-c and reduced diastolic blood 13 
pressure. Furthermore, the link between insulin resistance and over-sleeping requires further 14 
investigation to be able to make evidence recommendations based on the optimal sleeping 15 
time. As the current middle-aged population progresses ages, future research will also need to 16 
consider the impact of increased nocturnal light and electronic device exposure and 17 
interactions between circadian entrainment and MetS.   18 
Strengths and Limitations 19 
It is important to note that this is a cross-sectional survey and therefore lacks the ability to 20 
infer causal relationships. The measurements have been performed once and may be prone to 21 
measurement and reporting errors. However this methodology is commonly used in this field 22 
and this study used validated instruments and suitably qualified and trained staff, making the 23 
results comparable to other studies. The sleeping habits have been assessed only regarding 24 
quantity and not quality or patterns (e.g., daytime nap duration), which could be equally 25 
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important, this was employed as the measuring method is easier to implement and could be 1 
implemented in routine clinical practice. Furthermore, sleep duration was self-reported and 2 
not objectively measured (e.g., via polysomnography); however, in an outpatient 3 
environment, sleep data will also be self-reported and thus this information can be of 4 
practical importance. Moreover, the data on sleep were not obtained separately for weekends 5 
and weekdays, although it is common among elderly to adopt the same pattern every day, this 6 
could increase the robustness of the data. The use of individual component factors rather than 7 
a global assessment of MetS could also be viewed as a limitation, as well as the high MetS 8 
prevalence in the study sample, which is common among elderly though. However, with the 9 
different classifications of MetS and the inclusion of raised markers or treatment it was felt 10 
that in this analysis considering each feature in isolation would provide a clearer view of 11 
CVD risk. Additionally, without considering the separate features it would not be possible to 12 
elucidate the differing effects of sleep quantity on the component features.  13 
Conclusions 14 
Increasing sleep duration has a variable effect on component features of Met S in an elderly 15 
population, with changes to waist circumference and LDL-c potentially increasing risk and 16 
reductions in diastolic blood pressure reducing risk, but may increase risk of other conditions. 17 
Sleep duration appears to influence markers of metabolic health in apparently healthy older 18 
adults; however, more work is required in order to elucidate mechanisms and how aging 19 
influences the role of sleep duration on health. It is logical that clinicians as part of lifestyle 20 
assessment, including quantifying sleep in subjects with existing MetS risk factors should 21 
become an integral part of clinical practice; especially taking into account that MetS is a 22 
CVD risk factor of great significance. 23 
 24 
 25 
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 1 
Table 1. Lifestyle, psychosocial and clinical characteristics of the MEDIS study 
participants (n = 3130) in respect to their gender. 
Characteristics All Males 
(n=1574) 
Females 
(n=1556) 
p 
Age (years) 74.2±7.34 74.8±7.49 73.6±7.14 <0.001 
Daily sleep (hours) 8.30±1.76 8.30±1.75 8.20±1.77 0.53 
Body Mass Index (kg/m
2
) 28.3±4.67 27.8±4.12 28.9±5.10 <0.001 
Smoking (current), yes (%) 15.6 26.1 5.2 <0.001 
MedDietScore (0-55) 32.5±4.99 32.5±4.98 32.5±5.00 0.88 
Daily Walking time (minutes)* 60 (30,120) 60 (30,120) 60 (25,120) 0.24 
Waist circumference (cm) 101±14.0 102±12.3 100±15.1 0.001 
Fasting glucose levels (mg/dL) 116±39.5 116±37.7 115±41.2 0.72 
Diabetes mellitus, yes (%) 22.3 22.8 21.8 0.571 
Diabetes treatment (disk and/or 
insulin), yes (%) 
13.38 14.2 12.6 0.283 
Triglycerides (mg/dL)* 119 (92,160) 119 (95,160) 118 (91,156) 0.55 
LDL-cholesterol (mg/dL) 126±41.3 123±39.3 129±22.6 0.03 
HDL-cholesterol (mg/dL)* 50 (43,60) 46 (40,54) 55 (46,63) <0.001 
Hyperlipidemia, yes (%) 47.7 40.8 54.9 <0.001 
Hyperlipidemic treatment, yes (%) 30.3 35.3 25.5 <0.001 
Systolic Blood Pressure (mmHg) 135±21.9 135±19.8 134±23.6 0.86 
Diastolic Blood Pressure (mmHg) 77.6±13.0 77.8±12.0 77.3±14.0 0.46 
Hypertension, yes (%) 62.3 55.7 68.9 0.012 
Hypertension treatment, yes (%) 54.6 47.4 62.1 0.02 
*values are presented as median (25
th
, 75
th
 percentiles). P-values derived from Student's t-test 2 
or non-parametric Mann-Whitney test (*) for non-continuous variables and chi-squared test 3 
for nominal variables 4 
5 
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 1 
Table 2. Lifestyle, psychosocial and clinical characteristics of the MEDIS study 
participants (n = 3130) in respect to their Metabolic Syndrome (MetS) status. 
Characteristics MetS (65.3%)  No MetS (34.7%)  P 
Age (years) 74.3±6.62 74.8±7.36 0.50 
Gender, male (%) 29.6 33.3 0.49 
Daily sleep (hours) 7.91±1.82 7.59±1.56 0.42 
Body Mass Index (kg/m
2
) 30.8±4.37 28.2±3.81 <0.001 
Smoking (current), yes (%) 8.5 7.5 0.76 
MedDietScore (0-55) 33.0±5.16 32.5±6.57 0.53 
Daily Walking time (minutes)* 60 (30,120) 120 (30,240) 0.03 
Waist circumference (cm) 107±10.4 96.8±12.5 <0.001 
Fasting glucose levels (mg/dL) 126±36.9 101±36.1 <0.001 
Triglycerides (mg/dL)* 132 (102,177) 100 (86,119) <0.001 
LDL-cholesterol (mg/dL) 130±40.2 115±44.1 0.003 
HDL-cholesterol (mg/dL)* 49 (42,58) 56 (49,62) <0.001 
Systolic Blood Pressure (mmHg) 138±15.4 123±14.2 <0.001 
Diastolic Blood Pressure (mmHg) 79.5±9.62 74.9±9.96 <0.001 
*values are presented as median (25
th
, 75
th
 percentiles). P-values derived from Student's t-test 2 
or non-parametric Mann-Whitney test (*) for non-continuous variables and chi-squared test 3 
for nominal variables 4 
 5 
6 
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 1 
Table 3. Multivariable linear logistic regression model for the role of hours of total sleep in Metabolic Syndrome 
components (n = 3130). 
Dependent Variable 
b coefficient  
(per 1 hour)  
Standard  
error 
95% Confidence 
Interval 
p 
Waist circumference (cm) (Model 1) 0.70 0.32 (0.07,1.32) 0.03 
Waist circumference (cm) (Model 2) 0.91 0.29 (0.34,1.49) 0.002 
Fasting glucose levels (mg/dL) (Model 1) 1.23 1.03 (-0.79,3.25) 0.23 
Fasting glucose levels (mg/dL) (Model 2) 0.73 1.13 (-1.51,2.96) 0.52 
Triglycerides (mg/dL)* (Model 1) 0.001 0.01 (-0.03,0.03) 0.95 
Triglycerides (mg/dL)* (Model 2) 0.006 0.02 (-0.02,0.04) 0.69 
LDL-cholesterol (mg/dL) (Model 1) 5.14 1.54 (2.10,8.19) 0.001 
LDL-cholesterol (mg/dL) (Model 2) 3.84 1.62 (0.63,7.05) 0.02 
HDL-cholesterol (mg/dL)* (Model 1) -0.001 0.01 (-0.02,0.02) 0.92 
HDL-cholesterol (mg/dL)* (Model 2) -0.005 0.01 (-0.03,0.02) 0.67 
Systolic Blood Pressure (mmHg) (Model 1) 0.24 0.38 (-0.50,0.98) 0.52 
Systolic Blood Pressure (mmHg) (Model 2) 0.32 0.39 (-0.46,1.09) 0.42 
Diastolic Blood Pressure (mmHg) (Model 1) -0.92 0.29 (-1.49,-0.34) 0.002 
Diastolic Blood Pressure (mmHg) (Model 2) -0.98 0.30 (-1.57,-0.39) 0.001 
LDL: Low-Density Lipoprotein; HDL: High-Density Lipoprotein. Model 1: All models have been adjusted for age and 
gender. Model 2: All models have been adjusted for age, gender, Body Mass Index, Daily walking, MedDietScore, and 
smoking status. *indicates that logarithmic transformation has been used to normalize the dependent variable  
 2 
 3 
 4 
 5 
6 
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Figure 1. Multivariable linear logistic regression model coefficients for the role of hours of 1 
total sleep in Metabolic Syndrome components (n = 3130). 2 
 3 
Increase means positive association with sleep hours, whereas, decrase means negative 4 
association between sleep hours and features of MetS. 5 
LDL: Low-Density Lipoprotein; HDL: High-Density Lipoprotein. Model 1: All models have been adjusted for 6 
age and gender. Model 2: All models have been adjusted for age, gender, Body Mass Index, Daily walking, 7 
MedDietScore, and smoking status. Logarithmic transformation has been used to normalize the dependent 8 
variables HDL-cholesterol and Triglycerides levels. 9 
10 
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